Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

December 18, 2025 — Amphenol Corporation (NYSE: APH) is back in focus today as the stock steadies near the $130 level after a volatile stretch that has included sharp swings in volume, a pullback from recent highs, and fresh debate about whether the company’s AI-and-data-center tailwinds still justify a premium valuation. As of the latest available trading update on Dec. 18, 2025, APH shares were around $129 (day range roughly $126.7–$130.4), with a market cap near $156 billion. Amphenol stock price action: what’s happening on Dec. 18, 2025 Today’s story starts with context: on Wednesday, Dec. 17, Amphenol fell 2.03%
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Dec. 18, 2025 — Birkenstock Holding plc (NYSE: BIRK) delivered a classic “beat-and-drop” session: strong fiscal 2025 results and record revenue were overshadowed by a more cautious fiscal 2026 outlook that bakes in tariff and currency pressure. SEC+1 As of the latest available trade on Dec. 18, Birkenstock shares were at $42.58, down about 8% on the day, after swinging between $39.73 and $46.75 in heavy volume. The market’s message was blunt: investors liked what Birkenstock just did, but they’re repricing what it may earn next—especially if tariffs and foreign-exchange (FX) headwinds prove sticky. What’s happening with Birkenstock stock today
Boeing (BA) Stock News Today: Dec. 18, 2025 Updates, Analyst Forecasts, and What’s Next for The Boeing Company

Boeing (BA) Stock News Today: Dec. 18, 2025 Updates, Analyst Forecasts, and What’s Next for The Boeing Company

December 18, 2025 — Boeing stock (NYSE: BA) is back in the spotlight as investors weigh a mix of near-term catalysts (labor talks tied to the Spirit AeroSystems integration) and longer-run drivers (production normalization, certification milestones, and a growing defense pipeline). In afternoon trading, Boeing shares were up about 1.4% around $209. Stock Analysis Below is a detailed, publication-ready breakdown of the biggest Boeing headlines on 18.12.2025, plus the latest consensus forecasts and the key signposts that could define BA’s next move. Boeing stock price action on Dec. 18, 2025 Boeing shares traded higher Thursday, hovering near $209 and rising
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

December 18, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) saw its shares slide sharply in Thursday trading, a reminder that clinical-stage biotech stocks can move fast even when there’s no single headline screaming for attention. EWTX finished the session around $20.35, down roughly 8.8% from the prior close, after trading between about $20.33 and $22.81. StockAnalysis That drop matters because the Edgewise story is still mostly about future clinical readouts and regulatory path clarity, not current product revenue. The company is advancing late-stage work in muscular dystrophies (with its lead program, sevasemten) and also developing cardiac sarcomere modulators for conditions
Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture plc stock (NYSE: ACN) was lower Thursday after the consulting and IT services giant reported fiscal first-quarter 2026 results that topped Wall Street expectations—but delivered a second-quarter revenue outlook that, at the midpoint, came in slightly under analyst forecasts. As of the latest update Thursday afternoon, Accenture shares traded around $270.84, down about 1% from the prior close, after swinging between roughly $262.00 and $285.34 intraday. The market’s reaction underscores the split narrative surrounding Accenture stock in late 2025: strong demand for AI-led work is translating into faster “advanced AI” bookings and revenue, but investors remain alert to near-term
Salesforce (CRM) Stock News Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Acquisition, and Fresh Analyst Price Targets

Salesforce (CRM) Stock News Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Acquisition, and Fresh Analyst Price Targets

December 18, 2025 — Salesforce, Inc. (NYSE: CRM) is ending the year with a familiar mix of catalysts that matter to stock investors: a new AI distribution channel, another targeted acquisition in its “agentic” strategy, and a steady drumbeat of analyst updates as Wall Street tries to put a price on the company’s next growth phase. As of 17:47 UTC on Thursday, Dec. 18, Salesforce shares traded at $257.52, down roughly 0.2% on the session. Below is a roundup of the major news, forecasts, and analyst takes circulating on Dec. 18, 2025, plus what they may mean for the CRM
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries Incorporated (NYSE: ABM) stock was sharply lower in Thursday trading (December 18, 2025), with shares recently changing hands near $43.13, down about 10.6% from the prior close after a volatile session that saw the stock trade between $43.02 and $47.63. The move follows a dense burst of company updates released on December 17: ABM’s fiscal fourth-quarter and full-year 2025 results, a fiscal 2026 outlook, a dividend increase, and a major acquisition announcement—plus fresh analyst commentary today that put margins and leverage back at the center of the debate. GlobeNewswire+2ABM+2 Why ABM stock is moving today The immediate catalyst
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer (NYSE: PFE) stock is trying to regain its footing on Thursday, December 18, 2025, after a volatile mid-December stretch that put the spotlight back on three recurring themes for shareholders: the post-COVID revenue reset, looming loss-of-exclusivity (LOE) headwinds, and whether Pfizer’s rebuilt pipeline can drive durable growth later this decade. As of 18:26 UTC (1:26 p.m. ET) on Dec. 18, Pfizer shares traded around $25.04, essentially flat on the day. What’s driving Pfizer stock on Dec. 18, 2025 Here are the major, market-moving Pfizer headlines and developments investors are digesting today: Pfizer stock price check: stability after a sharp
Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

WASHINGTON — President Donald Trump signed a new executive order Thursday aimed at accelerating the federal reclassification of marijuana, a rare, headline-grabbing shift in U.S. drug policy that could ripple across medical research, the cannabis industry, and state-by-state enforcement. WHEC.com+1 But the marijuana move isn’t happening in isolation. On Dec. 18, 2025, multiple executive-order-driven storylines collided across Washington—from federal efforts to curb state AI regulation, to sweeping health-policy proposals tied to an earlier Trump order, to continued fallout from a proxy-voting order reshaping corporate governance debates. My Journal Courier+3The White House+3HHS+3 The big news today: Trump signs an executive order to fast-track
18 December 2025
Texas Instruments Incorporated Stock (TXN) Today: New Sherman Fab Starts Production as Analysts Split on 2026 Outlook

Texas Instruments Incorporated Stock (TXN) Today: New Sherman Fab Starts Production as Analysts Split on 2026 Outlook

Texas Instruments Incorporated (NASDAQ: TXN) is back in focus on December 18, 2025, as fresh headlines about its U.S. manufacturing expansion collide with a still-mixed Wall Street outlook for margins and growth into 2026. The chipmaker has officially begun producing chips at its newest 300mm wafer fabrication facility in Sherman, Texas, a milestone TI says will help it scale “foundational” semiconductors used across everything from vehicles and factory equipment to consumer electronics and data centers. Texas Instruments At the same time, Texas Instruments stock is trading in a market that continues to debate two competing narratives: a long-cycle analog recovery
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems, Inc. (NYSE: INSP) stock tumbled sharply on Thursday, December 18, 2025, after a key Medicare coding tailwind that had fueled recent optimism suddenly looked far less certain. By early afternoon in the U.S. session, INSP was down in the mid-to-high teens, reflecting investor anxiety that a reimbursement “upgrade” tied to a specific billing code may not stick—at least not in the clean, nationwide way many had modeled. MarketBeat What happened to INSP stock on 18.12.2025? The immediate catalyst: two Medicare Administrative Contractors (MACs)—CGS and Noridian—reportedly pulled CPT code 64568 for hypoglossal nerve stimulation (HGNS) and redirected billing
Natural Gas Price Today at 2:00 PM ET, Dec. 18, 2025: NYMEX Slips Below $4 After EIA Storage Draw, Warm Forecasts and LNG Crosscurrents

Natural Gas Price Today at 2:00 PM ET, Dec. 18, 2025: NYMEX Slips Below $4 After EIA Storage Draw, Warm Forecasts and LNG Crosscurrents

NEW YORK/LONDON — Natural gas traders are ending the week’s mid-December session with a familiar tug-of-war: a winter-sized storage withdrawal and near-record LNG feedgas demand on one side, and softer near-term weather forecasts plus a still-ample U.S. storage cushion on the other. By early afternoon on Thursday, December 18, natural gas prices had swung sharply from the morning’s highs and slipped back under the psychologically important $4.00 per million British thermal units (mmBtu) level—highlighting how quickly the market is repricing every update to weather models and export flows. Investing.com+2TradingView+2 Natural gas price today at 2:00 PM ET Around early afternoon

Stock Market Today

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Go toTop